[新聞] 武漢肺炎進入三期或四期試驗的治療方式已刪文
Remdesivir (RNA Polymerase inhibtor)
Estimated Study Start Date : February 5, 2020
Estimated Primary Completion Date : April 3, 2020 (Severe)
Estimated Primary Completion Date : April 10, 2020 (Mild/Moderate)
Estimated Study Completion Date : April 27, 2020
ASC09F、Ritonavir (HIV用藥,Protease Inhibitors)與Oseltamivir (克流感)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : May 1, 2020
Estimated Study Completion Date : July 1, 2020
Darunavir and Cobicistat (HIV用藥,Protease Inhibitors)
Estimated Study Start Date : January 30, 2020
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : December 31, 2020
Hydroxychloroquine (奎寧)
Estimated Study Start Date : February 6, 2020
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : December 31, 2020
Arbidol (流感藥物,阻止病毒進入細胞)
Estimated Study Start Date : February 7, 2020
Estimated Primary Completion Date : July 1, 2020
Estimated Study Completion Date : December 30, 2020
Arbidol與Interferon (干擾素)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : July 1, 2020
Abidol、Oseltamivir、Lopinavir/ritonavir (HIV用藥,Protease Inhibitors)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : July 1, 2020
IVIG (Severe cases)
Estimated Study Start Date : February 10, 2020
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : June 30, 2020
Methylprednisolone (Severe cases)
Actual Study Start Date : January 26, 2020
Estimated Primary Completion Date : April 25, 2020
Estimated Study Completion Date : December 25, 2020
資料來源:https://clinicaltrials.gov/ct2/home
搜尋2019-nCoV,選介入性研究(Interventional)、第三期(Phase 3)或第四期(Phase 4)
研究細節可以自己看。
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.137.83.46 (臺灣)
※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1581273590.A.411.html
Stock 近期熱門文章
97
178
202
505
PTT職涯區 即時熱門文章